Truway Health Advances Long COVID Research with GenBank Submission Linked to NCBI BioProject PRJNA1476232

FOR IMMEDIATE RELEASE ONLY

June 10, 2026

Truway Health, Inc. announced the submission of genomic sequence records to the National Center for Biotechnology Information (NCBI) GenBank database under Submission SUB16248244, representing a significant advancement in the company's Long COVID host genomics research program.

The submission is linked to the previously established BioProject PRJNA1476232, entitled Truway Health Long COVID Cohort Host Genomics Study, and integrates accessioned BioSample and Sequence Read Archive (SRA) resources into a unified genomic research framework.

Building a Connected Genomic Research Infrastructure

The project was designed to create a structured and publicly discoverable genomic resource supporting future investigations into host biology, immune function, and genomic factors associated with Long COVID and related post-viral conditions.

The current NCBI resource architecture includes:

• BioProject: PRJNA1476232

• Five accessioned BioSamples

• Five host genomic Whole Genome Sequencing datasets

• GenBank sequence submissions linked to the study framework

By connecting BioProject, BioSample, SRA, and GenBank resources, the study establishes a durable foundation for future translational research and data integration efforts.

Study Design

The initial pilot cohort includes five participant-derived whole blood specimens processed for host genomic characterization. Sequencing was performed using the Illumina NovaSeq 6000 platform and archived through NCBI's Sequence Read Archive infrastructure.

The study focuses on creating a high-quality genomic resource that can support future investigations into:

• Host genomic variation

• Immune response pathways

• Recovery and resilience mechanisms

• Biomarker discovery

• Precision medicine applications for post-viral illness

Importantly, the current submission is focused on data infrastructure and resource development rather than reporting clinical conclusions or validated genomic associations.

Why This Matters

Long COVID remains one of the most complex challenges in modern medicine. While substantial effort has been directed toward understanding viral persistence and immune dysregulation, comparatively few publicly accessible genomic datasets integrate participant samples, sequencing data, and linked archival resources within a unified framework.

The Truway Health initiative seeks to contribute to the broader scientific ecosystem by establishing resources that may support:

• Independent validation studies

• Multi-center collaborations

• Future genomic analyses

• Variant interpretation efforts

• Multi-omics integration

Looking Ahead

Future development goals for the program include:

• Expansion of cohort enrollment

• Additional sequencing datasets

• Enhanced sequence annotation

• Variant catalog development

• Integration with future phenotype and biomarker studies

• Potential submission of validated findings to public genomic repositories and scientific journals

As the project grows, Truway Health remains committed to responsible scientific stewardship, transparent research practices, and the development of genomic resources that may advance understanding of Long COVID and related post-viral conditions.

Project Information

BioProject: PRJNA1476232
GenBank Submission: SUB16248244
Study: Truway Health Long COVID Cohort Host Genomics Study
Organization: Truway Health, Inc.
Status: Submitted – Awaiting Processing